Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study-A case-control study on women with incident coronary heart disease

Maturitas

Volumn 57, Issue 3, 2007, Pages 239-246

  Windler, Eberhard ^a   Zyriax, Birgit Christiane ^a   Eidenmüller, Britta ^a   Boeing, Heiner ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Cardiovascular protection; Cardiovascular risk; Coronary heart disease; Hormone replacement therapy; Postmenopausal women; Postmenopause; Prevention; Risk factors

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY RISK; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MEAT; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; WAIST HIP RATIO;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HUMANS; INCIDENCE; MENOPAUSE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

CORA;

EID: 34250029168     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2007.01.004     Document Type: Article

References (27)

1. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20 (1991) 47-63
2. Grodstein F., and Stampfer M.J. Estrogen for women at varying risk of coronary disease. Maturitas 30 (1998) 19-26
3. Psaty B.M., Heckbert S.R., Atkins D., et al. The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Int Med 154 (1994) 1333-1339
4. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280 (1998) 605-613
5. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
6. Anderson G.L., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
7. Manson J.E., et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349 (2003) 523-534
8. Mueck A.O., and Seeger H. Biochemical markers surrogating on vascular effects of sex steroid hormones. Gynecol Endocrinol 22 (2006) 163-173
9. Zyriax B.C., Boeing H., and Windler E. Nutrition is a powerful independent risk factor for coronary heart disease in women-the CORA study: a population-based case-control study. Eur J Clin Nutr 59 (2005) 1201-1207
10. Bohlscheid T.S., Hoting I., Boeing H., and Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 26 Suppl. 1 (1997) S59-S70
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
12. Marques-Vidal P., Mazoyer E., Bongard V., Gourdy P., Ruidavets J.B., Drouet L., et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25 (2002) 1371-1377
13. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 89 (2003) 2560-2571
14. Schulze M.B., Kroke A., Saracci R., and Boeing H. The effect of differences in measurement procedure on the comparability of blood pressure estimates in multi-centre studies. Blood Press Monit 7 (2002) 95-104
15. Rich-Ewards J.W., Manson J.E., Hennekens C.H., and Buring J.E. The primary prevention of coronary heart disease in women. N Engl J Med 332 (1995) 1758-1766
16. Rosenberg L., Palmer J.R., and Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 322 (1990) 213-217
17. Molarius A., Seidell J.C., Sans S., Tuomilehto J., and Kuulasmaa P. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int J Obes Relat Metab Disord 23 (1999) 116-125
18. Salpeter S.R., Walsh J.M.E., Greyber E., and Salpeter E.E. Coronary heart disease events associated with hormone therapy in younger and older women. J Gen Intern Med 21 (2006) 363-366
19. Shlipak M.G., Angeja B.G., Go A.S., Frederick P.D., Canto J.G., and Grady D. Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation 104 (2001) 2300-2304
20. Grodstein F., Manson J.E., and Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health (Larchmt) 15 (2006) 35-44
21. Kanaya A.M., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 138 (2003) 1-9
22. Margolis K.L., et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1178
23. Rijpkema A.H., van der Sanden A.A., and Ruijis A.H. Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review. Maturitas 12 (1990) 259-285
24. Walsh B.W., Schiff I., Rosner B., Greenberg L., Rabvnikar V., and Sacks F.M. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325 (1991) 1196-1204
25. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273 (1995) 199-208
26. Humphrey L.L., Chan B.K.S., and Harold C.S. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med 137 (2002) 272-284
27. Nelson H.D., Humphrey L.L., Nygren P., Teutsch S.M., and Allan J.D. Postmenopausal hormone replacement therapy: scientific review. JAMA 288 (2002) 872-881